Home » Topics » Regulatory

Regulatory
RSS

Novo Nordisk seeks approval for liquid GH in the U.S.

July 5, 1999

TAP Holdings seeks approval of erectile dysfunction treatment

July 2, 1999

FDA approves new formulation of Abbott's Norvir

July 1, 1999

Alza's Doxil approved in U.S. for treatment of refractory ovarian cancer

July 1, 1999

Genentech submits NDA to FDA for Nutropin Depot

June 30, 1999

FDA approves 15-mg Ditropan XL tablets

June 30, 1999

Fosamax receives FDA approval for glucocorticoid-induced osteoporosis

June 29, 1999

Ethyol approved by FDA for radiation-induced dry mouth

June 28, 1999

HIV protease inhibitor Agenerase now available in oral solution

June 28, 1999

Olanzapine effective in management of bipolar disorder

June 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...